RT Journal Article SR Electronic T1 Biophysical Characterization of A Novel SCN5A Mutation Associated with an Atypical Phenotype of Atrial and Ventricular Arrhythmias and Sudden Death JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.09.04.20186171 DO 10.1101/2020.09.04.20186171 A1 Mohammad-Reza Ghovanloo A1 Joseph Atallah A1 Carolina A. Escudero A1 Peter C. Ruben YR 2020 UL http://medrxiv.org/content/early/2020/09/07/2020.09.04.20186171.abstract AB Background Sudden cardiac death (SCD) is an unexpected death that occurs within an hour of the onset of symptoms. Hereditary primary electrical disorders account for up to 1/3 of all SCD cases in younger individuals and include conditions such as catecholaminergic polymorphic ventricular tachycardia (CPVT). These disorders are caused by mutations in the genes encoding cardiac ion channels, hence they are known as cardiac channelopathies. We identified a novel variant, T1857I, in the C-terminus of Nav1.5 (SCN5A) linked to a family with a CPVT-like phenotype characterized by atrial tachy-arrhythmias and polymorphic ventricular ectopy occurring at rest and with adrenergic stimulation, and a strong family history of SCD.Objective Our goal was to functionally characterize the novel Nav1.5 variant and determine a possible link between channel gating and clinical phenotype.Methods We first used electrocardiogram recordings to visualize the patient cardiac electrical properties. Then, we performed voltage-clamp of transiently transfected CHO cells. Lastly, we used the ventricular/atrial models to visualize gating defects on cardiac excitability.Results Voltage-dependences of both activation and inactivation were right-shifted, the overlap between activation and inactivation predicted increased window currents, the recovery from fast inactivation was slowed, there was no significant difference in late currents, and there was no difference in use-dependent inactivation. The O’Hara-Rudy model suggests ventricular afterdepolarizations and atrial Grandi-based model suggests a slight prolongation of atrial action potential duration.Conclusion We conclude that T1857I likely causes a net gain-of-function in Nav1.5 gating, which may in turn lead to ventricular afterdepolarization, predisposing carriers to tachy-arrhythmias.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by grants from Natural Science and Engineering Research Council (NSERC) of Canada and the Rare Disease Foundation to PCR and M-RG (CGS-D: 535333-2019 & MSFSS: 546467-2019), a MITACS Accelerate fellowship in partnership with Xenon Pharma, Inc to M-RG (IT10714).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of Alberta IRB ethics approval.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are freely available.